-
Uncategorized2 weeks ago
FDA’s radical transparency policy for rejections runs into legal uncertainty
FDA’s radical transparency policy for rejections runs into legal uncertainty
-
Uncategorized2 weeks agoHow advanced is China in diabetes drug discovery?
With the largest diabetic population and a pedigree in metabolic diseases, China is becoming one to watch in diabetes and obesity drug discovery. Diana Turner finds...
-
Uncategorized2 weeks agoSTAT+: A most-wanted fugitive appears to have been secretly working as a biotech executive
One of Rhode Island’s most-wanted fugitives — a former doctor convicted of sexual assault but on the run for 20 years — appears to have been...
-
Uncategorized2 weeks ago
2026 IPO class blooms again as BlossomHill, Latigo set sights on Nasdaq
Eighteen companies have gone public this year so far, putting 2026 on pace to record the highest number of IPOs since the pandemic-driven high of 2021.
-
Uncategorized2 weeks ago
New €25 Million BioReliance Testing Facility Opens at Merck KGaA Global Headquarters in Germany
New €25 Million BioReliance Testing Facility Opens at Merck KGaA Global Headquarters in Germany
-
Uncategorized2 weeks ago
Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvals
The FDA is currently reviewing Vertex Pharmaceuticals’ povetacicept, with a target action date of Nov. 30. If approved, the drug could benefit from campaigns from Novartis...
-
Uncategorized2 weeks agoSTAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
It’s officially a trend. For the third time in nine months, a pharma company has announced that it is assembling the largest AI supercomputer in the...
-
Uncategorized2 weeks ago
BMS expands AI footprint with Nvidia, aiming for ‘most powerful AI factory in life sciences’
Bristol Myers Squibb has entered into an expanded collaboration with Nvidia to create the biggest supercomputer for drug R&D, according to the announcement.
-
Uncategorized2 weeks agoSTAT+: Telemedicine company touted by Novo Nordisk stressed profits over patient safety, ex-workers say
Novo Nordisk, maker of Ozempic and Wegovy, lists the telehealth company LifeMD on its website as a provider that offers “legitimate medicine sourcing and patient support”...
-
Uncategorized2 weeks ago
Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
After the trailblazing approval of Sanofi’s Tzield for stage 3 type 1 diabetes, several companies, including SAB Biotherapeutics and Eledon Pharmaceuticals, are vying for a spot...
